NCT02241421View on ClinicalTrials.gov

The Importance of the Gut Microbiota in Body Weight Control and Insulin Sensitivity

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2014

Conditions
ObesityInsulin Resistance
Interventions
DRUG

Amoxicillin

DRUG

Vancomycin

OTHER

Placebo

Trial Locations (1)

Unknown

Maastricht University, Maastricht

All Listed Sponsors
collaborator

Top Institute Food and Nutrition

OTHER

lead

Maastricht University Medical Center

OTHER

NCT02241421 - The Importance of the Gut Microbiota in Body Weight Control and Insulin Sensitivity | Biotech Hunter | Biotech Hunter